Results 31 to 40 of about 42,857 (235)

Model to Predict Hyperbilirubinemia in Healthy Term and Near-Term Newborns with Exclusive Breast Feeding

open access: yes, 2014
Background: The aim of this study was to identify high-risk newborns who will subsequently hyperbilirubinemia; develop significant hyperbilirubinemia Days 4 to 10 of life by using the clinical data from the neonate; first three days of life.
曹伯年   +1 more
core   +1 more source

Hereditary hyperbilirubinemias

open access: yesSrpski arhiv za celokupno lekarstvo, 2014
Inherited disorders of bilirubin metabolism involve four autosomal recessive syndromes: Gilbert, Crigler- Najjar, Dubin-Johnson and Rotor, among which the first two are characterized by unconjugated and the second two by conjugated hyperbilirubinemia. Gilbert syndrome occurs in 2%-10% of general population, while others are rare. Except for
openaire   +3 more sources

SIGNIFICANT FACTORS INFLUENCING HYPERBILIRUBINEMIA AT SANTO YUSUF MOTHER AND CHILD HOSPITAL, NORTH JAKARTA USING BINARY LOGISTIC REGRESSION

open access: yesBarekeng
Hyperbilirubinemia is a problem that often occurs in newborns. The cause of hyperbilirubinemia is multifactorial including maternal, perinatal or environmental factors that can be risk factors in newborns.
Elsa Anna Pratiwi   +2 more
doaj   +1 more source

Curated human hyperbilirubinemia data and the respective OATP1B1 and 1B3 inhibition predictions

open access: yesData in Brief, 2017
Hyperbilirubinemia is a pathological condition, very often indicative of underlying liver condition that is characterized by excessive accumulation of conjugated or unconjugated bilirubin in sinusoidal blood.
Eleni Kotsampasakou   +2 more
doaj   +1 more source

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian   +12 more
wiley   +1 more source

Transcutaneous bilirubin level to predict hyperbilirubinemia in  preterm neonates. [PDF]

open access: yes, 2020
Background: Hyperbilirubinemia is common in neonates, with higher prevalence among preterm neonates, which can lead to severe hyperbilirubinemia. Assessment of total serum bilirubin (TSB) and the use of a transcutaneous bilirubinometry (TcB) are existing
Dewi Rahmawati, -   +4 more
core   +3 more sources

Clinical Significance of Acute Kidney Injury in Idiosyncratic Drug‐Induced Liver Injury: A Multicentric Propensity Scores Matched Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera   +15 more
wiley   +1 more source

Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia [PDF]

open access: yes, 2017
Hyperbilirubinemia, caused by the accumulation of unconjugated bilirubin, is one of the most common clinical diagnoses in both premature and term newborns.
Mei-Fei Yueh   +7 more
core   +1 more source

Outcome Analysis of Severe Hyperbilirubinemia in Neonates Undergoing Exchange Transfusion

open access: yes, 2022
Objective Severe neonatal hyperbilirubinemia can cause neurological disability or mortality if not effectively managed. Exchange transfusion (ET) is an efficient treatment to prevent bilirubin neurotoxicity.
Zhang, X. L.   +22 more
core   +1 more source

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Healthy volunteers (HVs) are essential for phase I trials, yet their recruitment and screening remain resource‐intensive and ethically complex. High screening failure (SF) rates highlight the need to evaluate and understand all aspects of the enrolment processes. We analyzed SF patterns in a large German HV cohort and explored participants' motivations,
Evelyn Krohmer   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy